Other Briefings
China Released Draft Encouraged Catalogue to Boost Foreign Investment
On December 20, 2024, China’s NDRC and the MOFCOM released the new draft version Encouraged Catalogue for Foreign Investment, revising the 2022 version. This draft is open for public feedback until January 20, 2025.
China Unveils Its First Set of Basic Standards for Corporate Sustainability (ESG) Disclosure
In December 2024, China introduced a Basic Standards of its Corporate Sustainability Disclosure Standards, aiming to guide businesses in aligning their sustainability practices with global ESG expectations.
Closing a Company in China: General Deregistration vs. Simplified Deregistration
This article highlights the differences between the general and simplified procedures when deregistering a company, explains the eligibility criteria, and clarifies common misunderstandings about these processes.
Encouraged Catalogue for Western China 2025: Trends and Opportunities
China has unveiled the latest Encouraged Catalogue for Western China 2025, in a bid to lure investment into prioritized areas of its vast western region.
New Guide for Cross-Border Personal Data Transfers in the GBA: A Roadmap for Compliance and Security
The Technical Committee for Information Security Technology (TC260) has released a new guide to standardize cross-border personal data transfers between the Chinese Mainland and Hong Kong within the Guangdong-Hong Kong-Macao Greater Bay Area (GBA). This guide introduces enhanced security standards and mutual recognition mechanisms, aiming to facilitate smoother data flows while ensuring robust protection of personal information.
China Expands Access for Wholly Foreign-Owned Hospitals: 9 Cities Open for Investment
China’s new policy allows wholly foreign-owned hospitals in 9 key cities, aiming to modernize healthcare, attract global expertise, and meet rising demand.
China Opens Doors to Foreign Investment in Cell Therapy and Wholly Foreign-Owned Hospitals in Pilot Cities
China has initiated a new round of foreign investment relaxation pilots in selected cities, permitting foreign investment in cell and gene therapy as well as wholly foreign-owned hospitals.
Capitalizing on China’s Organic Boom: Certification, Trends, and Opportunities
China’s organic product market is the third largest globally. Understanding the certification process and trends is crucial for stakeholders looking to capitalize on the lucrative opportunities.
